Clinical Trial Update: Rapamycin - Effects on Alzheimer's and Cognitive Health [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating rapamycin for effects on Alzheimer's disease and cognitive health is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 2 | Status: RECRUITING